EMA heads urges greater transparency for clinical drug trials

10/22/2013 | MedCityNews.com

Guido Rasi, executive director of the European Medicines Agency, says that the release of clinical trial data would increase efficiency and cost-effectiveness in drug development, becoming a boon to drug companies rather than creating the loss of competitive advantage they fear. His article, with EMA co-authors, appears in the New England Journal of Medicine. AbbVie and InterMune have filed lawsuits to prevent such data releases.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA